31 Jul 2026

Posted its best-ever quarter (EBITDA ₹845 cr, +65% YoY; PAT +101%; margin 26%) and management quantified two forward drivers — roughly ₹300 cr of annual savings from the Equinor LNG contract, and Gopalpur TAN (96% complete) plus Dahej Nitric Acid (93% complete) commissioning around end-Q2 FY27 and contributing profit from Q3, which it sizes at about ₹2,500 cr revenue and ₹800 cr EBITDA a year.

Won a ₹2,205.23 cr order from HAL for 122 AAAU units and 121 interface frames under the Uttam radar programme, executable over five years — a very large award relative to the company's size; the stock gapped up 7.2%.

An existing customer amended a purchase order upward by about ₹820 cr (USD 85.86 mn), taking that order to roughly ₹3,100 cr; management reiterated FY27 guidance of 80% revenue growth at 24% ±100bps EBITDA margin and said it may exceed the margin guidance, while adding a data-centre infrastructure vertical. Against that, BNP Paribas sold 1.89 lakh shares at ₹5,426 right after the results.

Revenue more than doubled (₹832 cr, +107% YoY) with PAT turning positive at ₹55 cr; contracted portfolio now 6.8 GW, a record 0.5 GW commissioned in the quarter, and management says data-centre and AI customers account for 42% of contracted RE power capacity, up roughly tenfold in two years to over 2.5 GW, guiding to 1.5 GW+ additions in FY27.

Reported a record quarter (revenue +78% YoY to ₹154.7 cr, PBT +139%), added a major global semiconductor customer, secured ₹240 cr of purchase orders and a ₹400 cr space contract, and planned a ₹300 cr QIP — but on 31 July a promoter-group entity sold 15.07 lakh shares via block deal, cutting its stake from 7.62% to 3.62%.

Added ₹16,000 cr of orders taking the book to ₹61,500 cr with revenue up 79.2% to ₹7,932 cr, and reaffirmed FY27 operating EBITDA of ₹7,000–7,700 cr alongside a ₹30,000 cr+ capex plan including 20 GWh of BESS — but operating margin fell to 18.15% from 22.5%, and one broker called it a weak start that raises the execution bar.

Received an LNTP from NTPC for the 2×800 MW Lara Stage-III thermal plant, classified by L&T's own convention as a 'mega' order (₹10,000–15,000 cr), and separately signed a six-year EPC framework agreement with Petroleum Development Oman plus a Kuwait oil infrastructure win.

Q1 was weak (PAT -13% YoY and -84% QoQ, stock gapped down 7.5%) on what management calls temporary customer approval delays, but it reiterated FY27 guidance of 20–25% revenue growth at 35–40% EBITDA margin, cited ₹226 cr of orders already received in FY27 against a roughly ₹2,654 cr order book, and approved a ₹10 cr acquisition of ST Advanced Composites for in-house radar composites.

Best-ever consolidated EBITDA of ₹8,469 cr (+98% YoY) and PAT of ₹5,294 cr (+152%), net debt down ₹2,223 cr with Net Debt/EBITDA at 0.30x and ICRA/CRISIL upgrades to AA+; board approved demerging the real estate business into Vedanta Property Platforms, and management guided to Aluminium EBITDA above $4bn in FY27 and scaling steel from 3 to 15 mtpa organically.

Management said it is confident of exceeding FY27 guidance by at least 10–15% with revenue growth above 30%, and Jefferies raised FY27–29 EPS estimates 12–13% expecting a 33% EPS CAGR — while simultaneously downgrading the practical case to Hold on the view that the upside is already in the price after a sharp rally.

Order book reached ₹13,245 cr, up 103% YoY, with Q1 revenue up 65% YoY and a bid book of over ₹6,200 cr — though 61% of that bid book is Adani group projects, following Adani Infra's 34.41% stake acquisition.

Commissioned 3.1 GWh of battery storage generating ₹226 cr revenue at an 82% EBITDA margin, targets 10+ GWh BESS and about 1.5 GW of renewable commissioning in FY27, and has locked in ₹1,400 cr+ of revenue from short-term BESS contracts; separately secured ₹3,404.57 cr of project funding.

Management put the order book at close to ₹18,000 cr, said the data-centre business can run at 25–30% EBIT margin, and plans ₹1,500 cr of investment over three years — while explicitly declining to give revenue guidance.

India revenue grew 19% YoY against IPM growth of 12%, taking it to number one in the domestic cardiac market, with semaglutide capturing 36% market share (oral plus injectable, per AIOCD PharmaTrac) and US revenue up 36%; base business EBITDA margin was 33.3%.

Revenue grew 39.7% YoY to ₹1,063 cr with PAT up 45.9% QoQ to ₹116 cr, active clients rose to 105 including two new $10–25 mn accounts, revenue from outside the top 20 clients improved to 33.4%, and it signed a GenAI medical-writing deal; management expects higher operating leverage in H2 FY27.

Record quarter with revenue up 64.9% YoY to ₹1,358 cr, adjusted EBITDA up 181% and PAT up 716% to ₹65 cr, processing 24.7 cr orders across 16,372 pin codes — though the Chief Product Officer resigned effective 7 August.

PAT rose 91% YoY to ₹2,003 cr on revenue up 39%, with EBITDA margin at 51.1% versus 39.2% a year earlier and record production and sales — the second large aluminium beat this week alongside Vedanta.

Approved a ₹90 cr greenfield dry-type transformer facility near Vadodara adding 2,300 MVA within 12–14 months, funded from internal accruals, explicitly because existing capacity utilisation is running above 100%; Q1 PAT rose 15% YoY and the stock jumped 6%.

Signed a share subscription, shareholders' and JV agreement with Japan's Galilei Holdings, which will take a 12.36% stake via a ₹190 cr preferential issue at ₹802.51 a share, alongside a new HoReCa JV (Galilei 60% / Ice Make 40%) with ₹88.19 cr of initial investment.

Order book rose 19% to ₹1,253 cr as of 24 July with Q1 total income up 40% YoY to ₹393 cr; Saudi Arabia operations turned cumulatively EBITDA positive and it deployed ₹92 cr of a planned ₹652 cr FY27 capex.

Madhusudan Kela's Singularity Fund bought 5.3 lakh shares via block deals, with a news channel reporting large HNI desk buy flows and a merger and turnaround plan said to be in the works.

Won a ₹1,600 cr order from NLC for 200 MW.

PAT rose 55% YoY to ₹171 cr with margin at 19.6% versus 16.9%, and the board approved ₹165 cr to expand the Gailpur plant by 11 million sq metres of glazed vitrified tile capacity because the existing plant is at 100% utilisation.

A subsidiary secured a $127.62 mn order from GAIL, marking entry into the oil and gas sector, alongside a smaller $1.21 mn Google purchase order.

Revenue grew 27.2% YoY to ₹326.6 cr with EBITDA margin of about 31.5%, above its own 29–30% guidance, and PAT up 33.4%; separately announced a silicone technology collaboration with Dow India.